CE offering--introductory offer Clostridium difficile associated disease (CDAD).
Segal
Phenelle
P
Infection Control Consulting Services, LLC.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D016360:Clostridioides difficile; D015897:Comorbidity; D017281:Cost of Illness; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D042241:Early Diagnosis; D004761:Enterocolitis, Pseudomembranous / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D010348:Patient Care Team / Q000458:organization & administration; D011322:Primary Prevention; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents